Literature DB >> 1425090

Dyslipidemias among normoglycemic members of familial NIDDM pedigrees.

M C Schumacher1, T M Maxwell, L L Wu, S C Hunt, R R Williams, S C Elbein.   

Abstract

OBJECTIVE: To examine the hypothesis that hyperinsulinemia among relatives of NIDDM probands will increase the prevalence of DLPs, we measured insulin levels and examined the frequency of DLPs among NIDDM pedigree members. RESEARCH DESIGN AND METHODS: We performed 2-h 75-g OGTTs and measured lipid and insulin levels of 287 family members and 86 spouses from 16 large Utah pedigrees ascertained for greater than or equal to 2 siblings with NIDDM.
RESULTS: One-hour insulin levels were higher among 206 family members with NGT than among 65 NGT spouses (483.3 vs. 361.7 pM, P = 0.05). Among the NGT family members, 32% had cholesterol levels at or above the age- and sex-specific 90th percentile level defined by the LRC studies, 33% had HDL levels less than or equal to 10th percentile, and 20% had triglyceride levels greater than or equal to 90th percentile. DLP (any of the three abnormalities) was found among 58% of NGT family members, which was significantly higher than the expected 27% (P less than 0.00001) and the prevalence among spouses of 45% (P less than 0.05). By NCEP criteria for hyperlipidemia, 40% of family members met criteria for diet and/or pharmacological therapy.
CONCLUSIONS: Normoglycemic members of NIDDM pedigrees have a high prevalence of DLPs, which approaches the prevalence in patients with NIDDM. Our data suggest that members of NIDDM pedigrees should be screened carefully for lipid abnormalities.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1425090     DOI: 10.2337/diacare.15.10.1285

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  5 in total

1.  Relationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the Diabetes Control and Complications Trial.

Authors:  Jonathan Q Purnell; Raj K Dev; Michael W Steffes; Patricia A Cleary; Jerry P Palmer; Irl B Hirsch; John E Hokanson; John D Brunzell
Journal:  Diabetes       Date:  2003-10       Impact factor: 9.461

2.  Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism.

Authors:  J E Henriksen; F Alford; A Handberg; A Vaag; G M Ward; A Kalfas; H Beck-Nielsen
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

3.  Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus.

Authors:  A Vaag; J E Henriksen; S Madsbad; N Holm; H Beck-Nielsen
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

Review 4.  Are there genetic paths common to obesity, cardiovascular disease outcomes, and cardiovascular risk factors?

Authors:  Tuomo Rankinen; Mark A Sarzynski; Sujoy Ghosh; Claude Bouchard
Journal:  Circ Res       Date:  2015-02-27       Impact factor: 17.367

5.  Leptin Receptor Gene Gln223Arg Polymorphism Is Not Associated with Hypertension: A Preliminary Population-Based Cross-Sectional Study.

Authors:  Geórgia das Graças Pena; Andre L S Guimarães; Rosângela R Veloso; Tatiana C Reis; Crizian S Gomes; João F R Neto; Gustavo Velasquez-Melendez
Journal:  Cardiol Res Pract       Date:  2014-02-13       Impact factor: 1.866

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.